BNTC

Benitec Biopharma Inc. BNTC

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BNTC PULM AKTX SONN GYRE HTGMQ
6M 17.34 % -7.79 % -12.13 % 227.91 % 10.64 % 0.00 %
YTD 22.68 % -34.91 % -22.30 % 164.38 % -30.67 % 0.00 %
1Y 45.87 % 135.98 % -64.65 % -8.64 % -37.63 % -66.67 %
3Y 222.88 % 43.90 % -90.98 % -98.11 % -5.99 % -99.98 %
5Y -70.25 % -78.90 % -97.55 % -99.97 % -88.42 % -100.00 %
10Y -99.12 % -99.41 % -99.74 % -100.00 % -99.33 % -100.00 %
From the beginning -99.75 % -99.86 % -99.71 % -100.00 % -99.94 % -100.00 %

Dividend

Benitec Biopharma Inc.

Gyre Therapeutics, Inc.